Visit COVID-19 resources

[Skip to Content]

Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome – (Eye 28, 1469 (December 2014))

11 December 2014

This news item is available to RCOphth members only, please log in below to access.

Members Login